Breakthrough system substantially increases cell production, with the potential to reach much higher productivity driven by platform’s significant scalability Flexible, industrial scale cell ...

LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

According to Germany’s Federal Ministry for Economic Affairs and Climate Action, battery cells are gaining in importance as a versatile and efficient means of storing energy. They are a driving force ...

Engineers from The University of Warwick's Integrative Synthetic Biology Center and Imperial College London's Department of Bioengineering have unveiled how to engineer microbial "cell-factories" to ...

Automated cell manufacturing company Mytos has signed an agreement with Aspen Neuroscience, a clinical-stage private company focused on autologous regenerative medicine, to automate the manufacture of ...

This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of traditional CAR T cell production. This innovative approach could ...